Medifast, Inc. (MED) Misses Q3 EPS by 1c, Sales Fall Short
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.16 -3.72%
EPS Growth %: -195.2%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -195.2%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q3 EPS of $0.36, $0.01 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $76.1 million versus the consensus estimate of $78.89 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
